BOSTON and VANCOUVER, BC, Nov. 10, 2025 /PRNewswire/ -- Alpha-9 Oncology ("Alpha-9" or "the Company"), a clinical-stage radiopharmaceutical company developing targeted cancer therapies, today ...
BOSTON and VANCOUVER, BC, Oct. 15, 2024 /PRNewswire/ -- Alpha-9 Oncology ("Alpha-9" or the "Company"), a clinical stage company developing radiopharmaceuticals for the treatment of cancer patients ...
Garching / Munich, Germany and VANCOUVER, British Columbia, April 24, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback